BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol 2018; 10(2): 186-212 [PMID: 29527256 DOI: 10.4254/wjh.v10.i2.186]
URL: https://www.wjgnet.com/1948-5182/full/v10/i2/186.htm
Number Citing Articles
1
Setareh Mobasheri, Nazanin Irani, Abbas Akhavan Sepahi, Fatemeh Sakhaee, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infectionGene 2018; 676: 95 doi: 10.1016/j.gene.2018.07.023
2
Abdulrazzaq N. Zghair, Nazar Sh. Mohammed, Sumayah Faruq Kasim. Gene Sequencing of Hepatitis C Virus Isolated from Patients with Liver DiseasesJournal of Pure and Applied Microbiology 2023; 17(2): 819 doi: 10.22207/JPAM.17.2.08
3
Runzhou Yu, Syed Muhammad Umer Abdullah, Yanni Sun. HMMPolish: a coding region polishing tool for TGS-sequenced RNA virusesBriefings in Bioinformatics 2023; 24(5) doi: 10.1093/bib/bbad264
4
Gusti Rizaldi, Achmad Fuad Hafid, Tutik Sri Wahyuni. Promising alkaloids and flavonoids compounds as anti-hepatitis c virus agents: a reviewJournal of Public Health in Africa 2023;  doi: 10.4081/jphia.2023.2514
5
Novie Amelia Chozie, Melati Arum Satiti, Damayanti Rusli Sjarif, Hanifah Oswari, Ni Ken Ritchie. The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experienceBlood Research 2022; 57(2): 129 doi: 10.5045/br.2022.2021219
6
Marta M Gaglia, Karl Munger. More than just oncogenes: mechanisms of tumorigenesis by human virusesCurrent Opinion in Virology 2018; 32: 48 doi: 10.1016/j.coviro.2018.09.003
7
Anjar Hermadi Saputro, Aluicia Anita Artarini, Daryono Hadi Tjahjono, Sophi Damayanti. The long and stumble way to find potential active compounds from plants for defeating hepatitis B and C: reviewPharmacia 2022; 69(3): 699 doi: 10.3897/pharmacia.69.e85160
8
Paulo Fernando da Silva Santos-Júnior, João Xavier de Araújo-Júnior, Edeildo Ferreira da Silva-Júnior. Inhibitors Targeting Hepatitis C Virus (HCV) EntryMini-Reviews in Medicinal Chemistry 2023; 23(11): 1193 doi: 10.2174/1389557522666220428115152
9
Ranjan Kumar Barman, Anirban Mukhopadhyay, Ujjwal Maulik, Santasabuj Das. Identification of Critical Host Targets for HCV Infection: A Systems Biology ApproachTransactions of the Indian National Academy of Engineering 2021; 6(3): 755 doi: 10.1007/s41403-021-00239-6
10
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting AntiviralsCancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
11
Tomás G. Villa, Ángeles Sánchez-Pérez, Carmen Sieiro. Oral lichen planus: a microbiologist point of viewInternational Microbiology 2021; 24(3): 275 doi: 10.1007/s10123-021-00168-y
12
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
13
Yoshihito Nagura, Takanori Suzuki, Kentaro Matsuura, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka. Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agentsHepatology Research 2024; 54(1): 32 doi: 10.1111/hepr.13962
14
Nour Mammari, Ysaline Krier, Quentin Albert, Marc Devocelle, Mihayl Varbanov. Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral InfectionsPharmaceuticals 2021; 14(8): 774 doi: 10.3390/ph14080774
15
Hui Tian, Zhenkun He. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB SignalingYonsei Medical Journal 2018; 59(4): 511 doi: 10.3349/ymj.2018.59.4.511
16
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Mariana Michelle Ramírez-Mejía. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting AntiviralsPathogens 2024; 13(4): 339 doi: 10.3390/pathogens13040339
17
Fatima Butt, Muhammad Shahid, Muhammad Hassan, Farah Tawakkal, Iram Amin, Samia Afzal, Rashid Bhatti, Rabia Nawaz, Muhammad Idrees. A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategiesEgyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00232-w
18
Ahmed S. Abdel‐Moneim. Occult hepatitis C infections: time to change the defined groupsMicrobiology and Immunology 2019; 63(11): 474 doi: 10.1111/1348-0421.12737
19
Varimadugu Aruna, A. Sneha, D. Sai Harshitha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 11 doi: 10.1016/B978-0-323-98806-3.00022-2
20
Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri. Metabolic changes in chronic hepatitis C patients receiving direct acting antiviralsF1000Research 2022; 11: 649 doi: 10.12688/f1000research.109397.1
21
B. Dominguez-Molina, K. Machmach, C. Perales, L. Tarancon-Diez, I. Gallego, J. L. Sheldon, M. Leal, E. Domingo, E. Ruiz-Mateos, Bryan R. G. Williams. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic CellsJournal of Virology 2018; 92(23) doi: 10.1128/JVI.01219-18
22
Érica da Silva Anselmo, Ana Paula Schermack, Líncon Bordignon Somensi, Alan Christhian Bahr, Elizama De Gregório. A IMPOSSIBILIDADE DO TRATAMENTO FARMACOLÓGICO PARA HEPATITE C CRÔNICA DEVIDO À INTERAÇÕES MEDICAMENTOSASRevista Contemporânea 2023; 3(6): 5665 doi: 10.56083/RCV3N6-052
23
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2021; : 89 doi: 10.1016/B978-0-7020-7584-1.00006-1
24
Tom Domovitz, Meital Gal-Tanamy. Tracking Down the Epigenetic Footprint of HCV-Induced HepatocarcinogenesisJournal of Clinical Medicine 2021; 10(3): 551 doi: 10.3390/jcm10030551
25
Vidya Ramdas, Rashmi Talwar, Moloy Banerjee, Advait Arun Joshi, Amit Kumar Das, Deepak Sahebrao Walke, Prashant Borhade, Usha Dhayagude, Rajesh Loriya, Ganesh Gote, Apparao Bommakanti, Aruna Sivaram, Gautam Agarwal, Arnab Goswami, Prashant Nigade, Maneesh Mehta, Vinod Patil, Dipak Modi, Hemant Kumar, Sadanand Mallurwar, Amruta Dash, Falguni Modi, Sandip Kuldharan, Pratima Srivastava, Minakshi Singh, Lakshmi Narasimham, Jayasagar Gundu, Sharad Sharma, Rajender Kumar Kamboj, Venkata P. Palle. Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical CandidateJournal of Medicinal Chemistry 2019; 62(23): 10563 doi: 10.1021/acs.jmedchem.9b01562
26
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, Thomas F. Baumert, Joachim Lupberger. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its GripInternational Journal of Molecular Sciences 2020; 21(9): 3057 doi: 10.3390/ijms21093057
27
Mohammad Hadi Nematollahi, Mehrnaz Mehrabani, Yaser Hozhabri, Maryamossadat Mirtajaddini, Siavash Iravani. Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesisHeliyon 2023; 9(10): e20428 doi: 10.1016/j.heliyon.2023.e20428
28
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidicsAnalytical Methods 2021; 13(6): 740 doi: 10.1039/D0AY02045A
29
Anne Olbrich, Hedda Wardemann, Stephan Böhm, Karen Rother, Che C Colpitts, Florian Wrensch, Thomas F Baumert, Thomas Berg, Julia Benckert. Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CThe Journal of Infectious Diseases 2019; 220(7): 1209 doi: 10.1093/infdis/jiz274
30
Reem El-Shenawy, Sally Farouk, Naiera Helmy, Noha Bader El Din. Hepatitis C - Recent Advances2023;  doi: 10.5772/intechopen.1001057
31
娜娜 李. Related Research Progress in Genotyping of Hepatitis C VirusAdvances in Clinical Medicine 2023; 13(05): 7598 doi: 10.12677/ACM.2023.1351061
32
Muhammad Kashif, Muhammad Irfan Majeed, Muhammad Asif Hanif, Ateeq ur Rehman. Surface Enhanced Raman Spectroscopy of the serum samples for the diagnosis of Hepatitis C and prediction of the viral loadsSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020; 242: 118729 doi: 10.1016/j.saa.2020.118729
33
Bianca Manole, Costin Damian, Simona-Eliza Giusca, Irina Draga Caruntu, Elena Porumb-Andrese, Catalina Lunca, Olivia Simona Dorneanu, Luminita Smaranda Iancu, Ramona Gabriela Ursu. The Influence of Oncogenic Viruses in Renal Carcinogenesis: Pros and ConsPathogens 2022; 11(7): 757 doi: 10.3390/pathogens11070757
34
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal DiseaseSerbian Journal of Experimental and Clinical Research 2021; 0(0) doi: 10.2478/sjecr-2021-0010
35
Le Chang, Wei Duan, Chuang Wang, Jian Zhang. miRNA-126 Inhibits Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells (BMSCs)Journal of Biomaterials and Tissue Engineering 2022; 12(4): 794 doi: 10.1166/jbt.2022.2943
36
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV InfectionJournal of Clinical Medicine 2021; 10(15): 3218 doi: 10.3390/jcm10153218
37
Rajdeep Shaw, Bhramar Dutta, Dipanjana Ghosh, Rajib Bandopadhyay. Hepatitis C—Route of Asymptomatic to Symptomatic Switch in Raising Hepatocarcinogenesis: Revisiting Nobel Prize 2020 in Physiology and MedicineNational Academy Science Letters 2023; 46(1): 51 doi: 10.1007/s40009-022-01192-w
38
Vukica Đorđević, Dobrila Stanković Đorđević, Branislava Kocić, Marina Dinić, Danka Sokolović, Jana Pešić Stanković, Daniele Vergara. The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase ActivityOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/6676057
39
Mahmood Reza Masoudi, Alireza Rafati. Immunogenicity against hepatitis C virus with mesenchymal stem cells of inbreed BALB/c mice sub cloned with HCVcp protein geneTransplant Immunology 2022; 74: 101651 doi: 10.1016/j.trim.2022.101651
40
Teshiwal Deress, Yihenew Million, Teshome Belachew, Mohabaw Jemal, Mekonnen Girma, Gianandrea Pasquinelli. Seroprevalence of Hepatitis C Viral Infection in Ethiopia: A Systematic Review and Meta-AnalysisThe Scientific World Journal 2021; 2021: 1 doi: 10.1155/2021/8873389
41
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virusGenes & Immunity 2019; 20(5): 436 doi: 10.1038/s41435-019-0066-z
42
Umesh Kumar Lilhore, Poongodi Manoharan, Jasminder Kaur Sandhu, Sarita Simaiya, Surjeet Dalal, Abdullah M. Baqasah, Majed Alsafyani, Roobaea Alroobaea, Ismail Keshta, Kaamran Raahemifar. Hybrid model for precise hepatitis-C classification using improved random forest and SVM methodScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36605-3
43
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review)Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6987
44
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infectionCytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
45
Noha H. Habashy, Marwa M. Abu-Serie. Major royal-jelly protein 2 and its isoform X1 are two novel safe inhibitors for hepatitis C and B viral entry and replicationInternational Journal of Biological Macromolecules 2019; 141: 1072 doi: 10.1016/j.ijbiomac.2019.09.080
46
Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo. Prevalence of the potential drug–drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in SpainGastroenterología y Hepatología (English Edition) 2019; 42(8): 465 doi: 10.1016/j.gastre.2019.09.001
47
Noha G. Bader El Din, Sally Farouk. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus InfectionJournal of Interferon & Cytokine Research 2024;  doi: 10.1089/jir.2024.0003
48
Özkan FİDAN. Investigation of Antiviral Potential of Food Carotenoids and Apocarotenoids against RNA-dependent RNA Polymerase of Hepatitis C VirusBitlis Eren Üniversitesi Fen Bilimleri Dergisi 2022; 11(3): 931 doi: 10.17798/bitlisfen.1161170
49
Anastasia Pechelyulko, Zhanna Andreeva-Kovalevskaya, Dmitriy Dmitriev, Viacheslav Lavrov, Yulia Massino, Alexey Nagel, Olga Segal, Olga S. Sokolova, Alexander Solonin, Yulia Tarakanova, Alexander Dmitriev. A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodiesProtein Expression and Purification 2021; 183: 105864 doi: 10.1016/j.pep.2021.105864
50
A.A. Khryanin, A.V. Sokolovskaia, V.K. Bocharova. Lichen planus associated with viral hepatitis C: new data, concepts and hypothesesKlinicheskaya dermatologiya i venerologiya 2023; 22(4): 426 doi: 10.17116/klinderma202322041426
51
Ali Almajid, Hassan Albarbari, Ali Bazroon, Hashim Al-Awami, Rahaf Aljurayyad, Razan Albadran , Zainab Alkhamis, Haider Alomair, Yamama Aljishi. Epidemiological Perspectives: A Four-Year Insight Into Hepatitis C Surveillance in the Kingdom of Saudi ArabiaCureus 2024;  doi: 10.7759/cureus.52646
52
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of hepatitis C cure with antivirals: why test and treat?Future Microbiology 2019; 14(5): 425 doi: 10.2217/fmb-2019-0041
53
Luis F. Pereira, John J. Faragon, Antoine Douaihy, Courtney E. Kandler. HIV Psychiatry2022; : 477 doi: 10.1007/978-3-030-80665-1_18
54
SK Mohiuddin Choudhury, XuSheng Ma, Sahibzada Waheed Abdullah, HaiXue Zheng. Activation and Inhibition of the NLRP3 Inflammasome by RNA VirusesJournal of Inflammation Research 2021; : 1145 doi: 10.2147/JIR.S295706
55
Adeline Kerviel, Mengyang Zhang, Nihal Altan-Bonnet. A New Infectious Unit: Extracellular Vesicles Carrying Virus PopulationsAnnual Review of Cell and Developmental Biology 2021; 37(1): 171 doi: 10.1146/annurev-cellbio-040621-032416
56
Elena Zocca, Silva Seraceni, Teresa Cafaro, Tamara Emanuela Cervone, Laura Cardarelli, Massimiliano Valisi, Isabella Polidori, Massimo Pieri, Flaminia Tomassetti, Francesco Broccolo. Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening ApproachDiagnostics 2024; 14(6): 570 doi: 10.3390/diagnostics14060570
57
Sarmad Falah Hasan, Zeyad Khalaf Maded, Muhannad Abdulla Alazzawy. Molecular detection of Hepatitis C virus (HCV) genotypes and viral loads in chronic hcv infected patients in Kirkuk, IraqMedical Journal of Babylon 2023; 20(Supplement 1): S31 doi: 10.4103/MJBL.MJBL_361_22
58
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, Pavel Ulbrich. Targeting the Virus Capsid as a Tool to Fight RNA VirusesViruses 2022; 14(2): 174 doi: 10.3390/v14020174
59
Kyo Izumida, Eiji Morita. The roles of HCV core protein and its binding host factor in virus assembly and releaseFrontiers in Virology 2024; 4 doi: 10.3389/fviro.2024.1383261
60
V. M. Tsyrkunov, V. P. Andreev, R. I. Kravchuk. CLINICAL MORPHOLOGY OF THE LIVER: HEPATOCYTES, ENDOMEMBRANE SYSTEMHepatology and Gastroenterology 2019; 3(1): 28 doi: 10.25298/2616-5546-2019-3-1-28-42
61
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams frameworkHealth Research Policy and Systems 2019; 17(1) doi: 10.1186/s12961-019-0436-z
62
Alexis A. Hatton, Fermin E. Guerra. Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like ReceptorsViruses 2022; 15(1): 52 doi: 10.3390/v15010052
63
Jia-Horng Kao, Chun-Yen Lin, Wan-Long Chuang, Yao-Yun Cheng, Jui-Yu Hu, Wen-Kai Liang, Peter Friebe, Stuart Palmer, Chin-Shiou Huang. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotypingDiagnostic Microbiology and Infectious Disease 2019; 94(4): 344 doi: 10.1016/j.diagmicrobio.2019.02.020
64
Bakht Biland, Mohsina Haq, Sardar Muhammad, Mohsan Subhani, Syed Gardezi, Najibul Haq, Nadeem Tehami. Frequency Distribution of Hepatitis C Virus Genotypes with Reference to Age and Sex in Various Districts of Khyber Pakhtunkhwa, PakistanEMJ Hepatology 2021; : 83 doi: 10.33590/emjhepatol/20-00268
65
Maria Carla Liberto, Nadia Marascio. Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”Journal of Clinical Medicine 2022; 11(2): 359 doi: 10.3390/jcm11020359
66
Adam Al-Hakim, Mark Kacar, Sinisa Savic. The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature ReviewJournal of Clinical Medicine 2024; 13(6): 1717 doi: 10.3390/jcm13061717
67
Po-Jen Hsiao, Chia-Jen Hsiao, Fu-Ru Tsai, Yen-Lin Hou, Chih-Chien Chiu, Wen-Fang Chiang, Kun-Lin Wu, Yuan-Kuei Li, Chen Lin, Jenq-Shyong Chan, Chi-Wen Chang, Chi-Ming Chu. From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for AlbuminuriaBioengineering 2022; 9(10): 509 doi: 10.3390/bioengineering9100509
68
Hongbo Zhang, Hongdan Wang, Youcai An, Ze Chen. Construction and application of adenoviral vectorsMolecular Therapy - Nucleic Acids 2023; 34: 102027 doi: 10.1016/j.omtn.2023.09.004
69
Shagufta Kamal, Asif Shahzad, Kanwal Rehman, Komal Tariq, Muhammad Sajid Hamid Akash, Muhammad Imran, Mohammed Ali Assiri. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C VirusCurrent Medicinal Chemistry 2024; 31(15): 2052 doi: 10.2174/0109298673234823230921090431
70
Shahina Mumtaz, Jawad Ahmed, Amina Gul, Shafiq Ahmed Tariq, Sami Siraj, Tahir Sarwar. Genetic Diversity of Hepatitis C Virus Genotype 3a Based on Complete Core Protein in Peshawar, PakistanJundishapur Journal of Microbiology 2020; 13(3) doi: 10.5812/jjm.98942
71
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An updateWorld Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
72
Anna D. Kashnikova, Tatiana N. Bystrova, Anastasia V. Polyanina, Artem A. Zalesskikh. Genetic Monitoring as a Component of Hepatitis C SurveillanceЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2022; : 76 doi: 10.35627/2219-5238/2022-30-11-76-81
73
Nur Amalin Zahirah Mohd Amin, Tuan Nur Akmalina Mat Jusoh, Ahmad Adebayo Irekeola, Rafidah Hanim Shueb. Hepatitis C: A Review on Current and Emerging Genotyping AssaysMalaysian Journal of Medicine and Health Sciences 2023; 19(5): 359 doi: 10.47836/mjmhs.19.5.41
74
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virusMicrobes and Infection 2019; 21(5-6): 263 doi: 10.1016/j.micinf.2019.06.008
75
Johan Noble, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing. Renal complications of liver diseasesExpert Review of Gastroenterology & Hepatology 2018; 12(11): 1135 doi: 10.1080/17474124.2018.1530984
76
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill, Shishir Shetty. Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular CarcinomaCancers 2022; 14(5): 1255 doi: 10.3390/cancers14051255
77
T.L. Hrydina . PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. ReviewMedical Science of Ukraine (MSU) 2022; 18(1): 64 doi: 10.32345/2664-4738.1.2022.09
78
K. Ghazal, O. Morales, C. Barjon, G. Dahlqvist, L. Aoudjehane, L. Ouaguia, N. Delhem, F. Conti. Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantationClinics and Research in Hepatology and Gastroenterology 2019; 43(3): 273 doi: 10.1016/j.clinre.2018.10.005
79
Satoshi Muraoka, Weiwei Lin, Mei Chen, Samuel W. Hersh, Andrew Emili, Weiming Xia, Tsuneya Ikezu. Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluidsMethods 2020; 177: 35 doi: 10.1016/j.ymeth.2020.02.002
80
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
81
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Shintaro Ogawa, Kei Fujiwara, Shunsuke Nojiri, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka. Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agentsHepatology Research 2022; 52(11): 919 doi: 10.1111/hepr.13823
82
Corey Saraceni, John Birk. A Review of Hepatitis B Virus and Hepatitis C Virus ImmunopathogenesisJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00095
83
Noila Talipova, Bakhtiyar Iriskulov, Sevara Azimova, Shakhnoza Latipova, D.V. Rudoy, A.V. Olshevskaya, E.N. Ponomareva, M.Yu. Odabashyan. Genetic characteristics of the course of chronic hepatitisE3S Web of Conferences 2023; 381: 01098 doi: 10.1051/e3sconf/202338101098
84
Ran Chen, Moubin Lin, Daming Gao. Major genomic mutations driving hepatocellular carcinomaGenome Instability & Disease 2023; 4(4): 239 doi: 10.1007/s42764-023-00103-7
85
Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient ElastographyJournal of Clinical Medicine 2021; 10(12): 2575 doi: 10.3390/jcm10122575
86
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewPanminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
87
Shereen A Saleh, Mohamed M Salama, Marwan M Alhusseini, Ghada A Mohamed. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antiviralsWorld Journal of Gastroenterology 2020; 26(21): 2864-2876 doi: 10.3748/wjg.v26.i21.2864
88
Demin Yu, Xinxin Zhang. Molecular Medical Microbiology2024; : 2247 doi: 10.1016/B978-0-12-818619-0.00119-2
89
Karim Nader, Amro Shetta, Sameh Saber, Wael Mamdouh. The potential of carbon-based nanomaterials in hepatitis C virus treatment: a review of carbon nanotubes, dendrimers and fullerenesDiscover Nano 2023; 18(1) doi: 10.1186/s11671-023-03895-5
90
Ahmet AKTAŞ, Engin ALTİNKAYA. DİREKT ETKİLİ ANTİVİRAL TEDAVİ ALAN KRONİK HEPATİT C HASTALARINDA ALFA FETOPROTEİN SONUÇLARININ DEĞERLENDİRİLMESİKırıkkale Üniversitesi Tıp Fakültesi Dergisi 2021; 23(2): 220 doi: 10.24938/kutfd.869839
91
Pei Zhou, Yawen Hu, Xiaoyan Wang, Luxuan Shen, Xinghao Liao, Yajuan Zhu, Jiadong Yu, Fulei Zhao, Yi Zhou, Hengshui Shen, Jiong Li. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.877939
92
Hyo Geun Choi, Jae Seung Soh, Jae Sung Lim, Song Yong Sim, Suk Woo Lee. Association between dementia and hepatitis B and C virus infectionMedicine 2021; 100(29): e26476 doi: 10.1097/MD.0000000000026476
93
KANNAN NARAYANAN, SUE ANN ZACHARIAH, SHEELA KURIAN V. ASPARTATE PLATELET RATIO INDEX AS A PREDICTOR OF SEVERITY OF FIBROSIS IN CHRONIC HEPATITS CAsian Journal of Pharmaceutical and Clinical Research 2023; : 69 doi: 10.22159/ajpcr.2023.v16i4.47535
94
Talari Praveen. Advances in Hepatology2021;  doi: 10.5772/intechopen.96734
95
G.S. Pancar, T. Kaynar. Nailfold capillaroscopic changes in patients with chronic viral hepatitisMicrovascular Research 2020; 129: 103970 doi: 10.1016/j.mvr.2019.103970
96
Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo. Prevalencia de las potenciales interacciones medicamentosas entre los antivirales de acción directa pangenotípicos y la medicación concomitante asociada a los pacientes con infección del virus de la hepatitis C crónica en EspañaGastroenterología y Hepatología 2019; 42(8): 465 doi: 10.1016/j.gastrohep.2019.03.014
97
Thanjavur Naveen, Lankipalli Tharachand Naidu, Rayi Ramesh, Mekala Charitha Devi. Recent Developments in Applied Microbiology and Biochemistry2021; : 35 doi: 10.1016/B978-0-12-821406-0.00005-9
98
María Fernanda Guerra, Javier Ampuero, Manuel Romero‐Gómez. Clinical Dilemmas in Viral Liver Disease2020; : 59 doi: 10.1002/9781119533481.ch10
99
Anika Jabin, Mohammad Fahim Uddin, Salauddin Al Azad, Ashfaque Rahman, Fawzia Tabassum, Pritthy Sarker, A K M Helal Morshed, Samiur Rahman, Fatima Fairuz Raisa, Musfiqur Rahman Sakib, Abeer Hasan Olive, Tabassum Islam, Ramisha Tahsin, Shahlaa Zernaz Ahmed, Partha Biswas, Mst. Umme Habiba, Mahbuba Siddiquy, Maryam Jafary. Target-specificity of different amyrin subunits in impeding HCV influx mechanism inside the human cells considering the quantum tunnel profiles and molecular strings of the CD81 receptor: a combined in silico and in vivo studyIn Silico Pharmacology 2023; 11(1) doi: 10.1007/s40203-023-00144-6